Pharma/Life Sciences: Corporate
France
13 years ranked
Pharma/Life Sciences: Corporate
France
13 years ranked
Provided by Dentons
Jean-Marc Grosperrin, a partner in Dentons' Paris office, is primarily involved in French and cross-border acquisitions, private equity transactions and industrial M&A transactions. Jean-Marc regularly advises major international groups as well as mid-sized companies.
Besides advising French and foreign companies on their acquisitions or divestitures in France and abroad, he also represents investment funds and managers in leveraged transactions.
Jean-Marc is Global Chair of the Life Science group and Co-head of the Europe and Paris Life Sciences groups. He also serves as a member of Dentons Europe Board.
Dentons (formerly Salans), 2004-Present
Started his career in 1998 at Willkie Farr & Gallagher, first in Paris and then in New York, where he concentrated on private equity acquisitions, mergers and restructurings issues.
Admitted to the Bar, Paris, 1998
English
French
Provided by Chambers
Jean-Marc Grosperrin boasts a leading corporate practice, advising pharmaceutical companies on commercial agreements and acquisitions.
Jean-Marc Grosperrin a une expertise reconnue en droit des sociétés, conseillant les entreprises pharmaceutiques sur des accords commerciaux et des acquisitions.
Provided by Chambers
Jean-Marc has enormous legal experience.
Jean-Marc is always responsive and gives good legal advice.
Jean-Marc is a high quality lawyer who is rigorous, reassuring, has a good sense of client service and helps to bring deals to fruition, while being accessible and without an oversized ego.
Jean-Marc est un avocat de grande qualité, rigoureux et rassurant. Il a un excellent sens du service à la clientèle et contribue à la conclusion des transactions, tout en étant accessible et sans prétention.
Jean-Marc a une vaste expérience juridique.
Jean-Marc est toujours réactif et donne de bons conseils juridiques.
2 items provided by Dentons
Chambers is the leading data and intelligence partner for the legal sector.